Showing results (11-20 of 49) with videos related to
Sort By:
Pageof 5
European Journal of Cancer (Oxford, England : 1990)|August 23, 2003
Tumour markers are poor predictors for relapse or progression in neuroblastomaT Simon, B Hero, D H Hunneman, et al.European Journal of Cancer (Oxford, England : 1990)|December 2, 2004
MYCN-status in neuroblastoma: characteristics of tumours showing amplification, gain, and non-amplificationRuediger Spitz, B Hero, M Skowron, et al.Klinische Padiatrie|August 8, 2002
The incidence of hearing impairment after successful treatment of neuroblastomaT Simon, B Hero, W Dupuis, et al.Nuklearmedizin. Nuclear Medicine|May 22, 2008
[Procedure guidelines for MIBG-scintigraphy in children]C Franzius, M Schmidt, B Hero, et al.Klinische Padiatrie|August 8, 2002
Topotecan in the treatment of refractory neuroblastoma and other malignant tumors in childhood - a phase-II-studyA Längler, A Christaras, K Abshagen, et al.Nuklearmedizin. Nuclear Medicine|December 7, 2006
[Dosimetry for therapeutic treatment of neuroblastoma by 131I-mIBG]F Sudbrock, W Eschner, M Schmidt, et al.Klinische Padiatrie|May 12, 2006
[Structure, use, and risks of biomaterial repositories of embryonal tumors]K Ernestus, T Pietsch, M Gessler, et al.Klinische Padiatrie|August 8, 2002
Neuroblastoma preoperatively treated as nephroblastoma: does inadequate therapy worsen the prognosis?B Hero, N Graf, T Simon, et al.Cancer|May 11, 2001
Metabolic activity and clinical features of primary ganglioneuromasB Geoerger, B Hero, D Harms, et al.Zentralblatt Fur Gynakologie|March 26, 2003
[Efficiency and side effects of antiretroviral treatment of HIV infected pregnant women]T Simon, A-M Funke, B Hero, et al.Pageof 5